Pharma · Private company

EMD Serono Research & Development Institute, Inc.

Track this companyFree. Adds EMD Serono Research & Development Institute, Inc. to your Dealase workspace and tells you when its record changes.

Clinical trials2517 recruiting or active

Pipeline programs43From trials and the company's site

Disclosed deals0None found yet

Cash runwayNot availablePrivate: no SEC financials

Pipeline43

AvelumabPhase 3 · Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
BevacizumabPhase 3 · Metastatic Colorectal CancerClinicalTrials.gov · fetched Nov 12, 2026
EnpatoranPhase 3 · Systemic Lupus Erythematosus (SLE)ClinicalTrials.gov · fetched Nov 12, 2026
EnpatoranPhase 3 · Systematic Lupus ErythematosusClinicalTrials.gov · fetched Nov 12, 2026
Precemtabart tocentecanPhase 3 · Metastatic Colorectal CancerClinicalTrials.gov · fetched Nov 12, 2026
Trifluridine/Tipiracil (FTD-TPI)Phase 3 · Metastatic Colorectal CancerClinicalTrials.gov · fetched Nov 12, 2026
AvelumabPhase 2 · Locally Advanced or Metastatic Urothelial CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
CemiplimabPhase 2 · Non-Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
JB100Phase 2 · Locally Advanced or Metastatic Urothelial CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
Lartesertib (M4076)Phase 2 · Ovarian CancerClinicalTrials.gov · fetched Nov 12, 2026
M1774Phase 2 · Non-Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
M5049 dosePhase 2 · DermatomyositisClinicalTrials.gov · fetched Nov 12, 2026
M6223Phase 2 · Locally Advanced or Metastatic Urothelial CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
M9140Phase 2 · Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
NiraparibPhase 2 · Ovarian CancerClinicalTrials.gov · fetched Nov 12, 2026
NKTR-255Phase 2 · Locally Advanced or Metastatic Urothelial CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
OsimertinibPhase 2 · Non-small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
Sacituzumab Govitecan (SG)Phase 2 · Locally Advanced or Metastatic Urothelial CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
TepotinibPhase 2 · Advanced (Stage IIIB/IV) Non-small Cell Lung Cancer (NSCLC) With MET Exon 14 (METex14) Skipping Alterations or MET AmplificationClinicalTrials.gov · fetched Nov 12, 2026
TepotinibPhase 2 · Non-small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
Tuvusertib (M1774)Phase 2 · Ovarian CancerClinicalTrials.gov · fetched Nov 12, 2026
5-fluorouracil (5-FU)Phase 1 · Colorectal CancerClinicalTrials.gov · fetched Nov 12, 2026
Abiraterone acetatePhase 1 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
AvelumabPhase 1 · Metastatic or Locally Advanced Unresectable Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
BevacizumabPhase 1 · Colorectal CancerClinicalTrials.gov · fetched Nov 12, 2026
Bintrafusp alfaPhase 1 · Metastatic Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
CapecitabinePhase 1 · Colorectal CancerClinicalTrials.gov · fetched Nov 12, 2026
Folinic acidPhase 1 · Colorectal CancerClinicalTrials.gov · fetched Nov 12, 2026
LartesertibPhase 1 · Metastatic or Locally Advanced Unresectable Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
M0324Phase 1 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
M1069Phase 1 · Metastatic or Locally Advanced Unresectable Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
M1774Phase 1 · Metastatic or Locally Advanced Unresectable Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
M3554Phase 1 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
M6223Phase 1 · Metastatic Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
M7437Phase 1 · Advanced Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
M9140Phase 1 · Colorectal CancerClinicalTrials.gov · fetched Nov 12, 2026
M9466Phase 1 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
mFOLFIRINOXPhase 1 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
NiraparibPhase 1 · Metastatic or Locally Advanced Unresectable Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
PembrolizumabPhase 1 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
Prednisone/PrednisolonePhase 1 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
TuvusertibPhase 1 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
TuvusertibPhase 1 · Metastatic or Locally Advanced Unresectable Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026

Clinical trials25

A Long-Term Extension (LTE) Study Of Enpatoran In Cutaneous Manifestations Of Lupus With Or Without Systemic Disease [Elowen-LTE]PHASE3 · RECRUITING · started Oct 22, 2026ClinicalTrials.gov NCT07840287 · fetched Nov 12, 2026
Feasibility of Remote Monitoring of Patients With Myasthenia GravisRECRUITING · started Aug 19, 2026ClinicalTrials.gov NCT07787247 · fetched Nov 12, 2026
A Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03)PHASE3 · RECRUITING · started May 6, 2026ClinicalTrials.gov NCT07549412 · fetched Nov 12, 2026
A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)PHASE3 · RECRUITING · started Apr 1, 2026ClinicalTrials.gov NCT07355218 · fetched Nov 12, 2026
A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic DiseasePHASE3 · RECRUITING · started Mar 10, 2026ClinicalTrials.gov NCT07332481 · fetched Nov 12, 2026
Anti-Ly6E Exatecan ADC M7437 in Advanced Solid TumorsPHASE1 · RECRUITING · started Feb 13, 2026ClinicalTrials.gov NCT07360314 · fetched Nov 12, 2026
M0324 as Monotherapy and in Combination With Pembrolizumab or Chemotherapy in Participants With Selected Advanced Solid TumorsPHASE1 · RECRUITING · started Oct 10, 2025ClinicalTrials.gov NCT07166601 · fetched Nov 12, 2026
Study of Anti-CEACAM5 ADC M9140 in Participants With Advanced Solid Tumors (PROCEADE PanTumor)PHASE1_PHASE2 · ACTIVE_NOT_RECRUITING · started Jan 29, 2025ClinicalTrials.gov NCT06710132 · fetched Nov 12, 2026
Anti-GD2 ADC M3554 in Advanced Solid TumorsPHASE1 · RECRUITING · started Nov 8, 2024ClinicalTrials.gov NCT06641908 · fetched Nov 12, 2026
Tuvusertib Combined With Niraparib or Lartesertib in Participants With Epithelial Ovarian Cancer (DDRiver EOC 302)PHASE2 · COMPLETED · started Oct 30, 2024ClinicalTrials.gov NCT06433219 · fetched Nov 12, 2026
M9466 Alone or in Combination in Advanced Solid Tumors (DDriver 501)PHASE1 · ACTIVE_NOT_RECRUITING · started Aug 7, 2024ClinicalTrials.gov NCT06421935 · fetched Nov 12, 2026
Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)PHASE3 · RECRUITING · started Jun 25, 2024ClinicalTrials.gov NCT06463587 · fetched Nov 12, 2026
Tuvusertib (M1774) in Combination With Cemiplimab in Participants With Non-Squamous NSCLC (DDRiver NSCLC 322)PHASE1_PHASE2 · COMPLETED · started Sep 13, 2023ClinicalTrials.gov NCT05882734 · fetched Nov 12, 2026
Study of M5049 in DM and PM Participants (NEPTUNIA)PHASE2 · TERMINATED · started Jan 19, 2023ClinicalTrials.gov NCT05650567 · fetched Nov 12, 2026
Met Non Small Cell Cancer Registry (MOMENT)RECRUITING · started Oct 4, 2022ClinicalTrials.gov NCT05376891 · fetched Nov 12, 2026
A Study of the Safety and Efficacy of Various Combinations of Avelumab as Therapy in Locally Advanced or Metastatic Urothelial Carcinoma (JAVELIN Bladder Medley)PHASE2 · ACTIVE_NOT_RECRUITING · started Aug 17, 2022ClinicalTrials.gov NCT05327530 · fetched Nov 12, 2026
Anti-CEACAM5 ADC M9140 in Advanced Solid Tumors (PROCEADE-CRC-01)PHASE1 · ACTIVE_NOT_RECRUITING · started Aug 4, 2022ClinicalTrials.gov NCT05464030 · fetched Nov 12, 2026
Study of Tuvusertib (M1774) in Combination With DNA Damage Response Inhibitor or Immune Checkpoint Inhibitor (DDRiver Solid Tumors 320)PHASE1 · COMPLETED · started Jun 7, 2022ClinicalTrials.gov NCT05396833 · fetched Nov 12, 2026
First in Human Study of M1069 in Advanced Solid TumorsPHASE1 · TERMINATED · started Mar 2, 2022ClinicalTrials.gov NCT05198349 · fetched Nov 12, 2026
First in Human Study of M6223PHASE1 · COMPLETED · started Jul 10, 2020ClinicalTrials.gov NCT04457778 · fetched Nov 12, 2026
Tuvusertib (M1774) in Participants With Metastatic or Locally Advanced Unresectable Solid Tumors (DDRiver Solid Tumors 301)PHASE1 · COMPLETED · started Dec 20, 2019ClinicalTrials.gov NCT04170153 · fetched Nov 12, 2026
A Study of Tepotinib Plus Osimertinib in Osimertinib Relapsed MET Amplified NSCLC (INSIGHT 2)PHASE2 · COMPLETED · started Sep 19, 2019ClinicalTrials.gov NCT03940703 · fetched Nov 12, 2026
Avelumab Program Rollover StudyPHASE3 · ACTIVE_NOT_RECRUITING · started Mar 22, 2019ClinicalTrials.gov NCT03815643 · fetched Nov 12, 2026
Phase Ib/II of TG4001 and Avelumab in HPV16 Positive R/M CancersPHASE1_PHASE2 · ACTIVE_NOT_RECRUITING · started Sep 1, 2017ClinicalTrials.gov NCT03260023 · fetched Nov 12, 2026
Tepotinib Phase II in NSCLC Harboring MET Alterations (VISION)PHASE2 · ACTIVE_NOT_RECRUITING · started Sep 13, 2016ClinicalTrials.gov NCT02864992 · fetched Nov 12, 2026